Related Experiment Video
Updated: Jul 2, 2026

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)
Published on: October 7, 2009
How we diagnose the antiphospholipid syndrome
Bill Giannakopoulos1, Freda Passam, Yiannis Ioannou
1Department of Medicine, Immunology, Allergy and Infectious Diseases, University of New South Wales, St George Hospital, Kogarah, Australia.
Antiphospholipid syndrome (APS) is a blood clotting disorder. This review highlights anti-beta 2-glycoprotein I antibodies for diagnosing APS and managing obstetric complications.
Area of Science:
- Immunology
- Hematology
- Obstetrics
Background:
- Antiphospholipid syndrome (APS) is an acquired thrombophilia causing venous and arterial events.
- Diagnosis relies on clinical and laboratory findings, with evolving criteria.
Purpose of the Study:
- To review laboratory and clinical aspects of APS.
- To focus on anti-beta 2-glycoprotein I (beta(2)GPI) antibodies and their diagnostic utility.
- To explore obstetric APS and associated thrombotic risks.
Main Methods:
- Review of laboratory assays including anti-beta 2-glycoprotein I (beta(2)GPI) ELISA, lupus anticoagulant, and cardiolipin ELISA.
- Analysis of clinical data and epidemiological findings related to APS.
- Discussion of diagnostic and risk stratification strategies.
Main Results:
- Anti-beta 2-glycoprotein I (beta(2)GPI) antibodies are crucial for APS classification.
- Combined use of assays aids in diagnosis and risk stratification.
- Epidemiological data offers insights into obstetric APS pathophysiology and thrombotic risk.
Conclusions:
- Anti-beta 2-glycoprotein I (beta(2)GPI) assays are vital for APS diagnosis and management.
- Understanding risk factors is key for preventing thrombotic complications in obstetric APS patients.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies